Maharashtra, India

Mahesh Kharade


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mahesh Kharade: Innovator in Isotretinoin Purification

Introduction

Mahesh Kharade is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceuticals, particularly in the purification of isotretinoin, a compound widely used in acne treatment. His innovative approach has the potential to enhance the quality and efficacy of this important medication.

Latest Patents

Kharade holds a patent for a process for the preparation of highly pure isotretinoin. This invention focuses on a purification process that effectively removes metal contamination and other impurities from isotretinoin. The method involves treating the compound with a base in a suitable solvent to create a solution, followed by adsorption, precipitation, and filtration or centrifugation. This process is crucial for obtaining isotretinoin that is safe and effective for use as a keratolytic agent.

Career Highlights

Mahesh Kharade is associated with Ipca Laboratories Limited, a prominent pharmaceutical company. His work at Ipca Laboratories has allowed him to apply his innovative ideas in a practical setting, contributing to the development of high-quality pharmaceutical products. His dedication to research and development has positioned him as a valuable asset in the industry.

Collaborations

Kharade has collaborated with notable colleagues such as Ashok Kumar and Dharmendra Singh. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, further enhancing the quality of their work.

Conclusion

Mahesh Kharade's contributions to the field of isotretinoin purification exemplify the impact of innovation in pharmaceuticals. His patent and work at Ipca Laboratories Limited highlight the importance of developing effective and safe treatments for acne. His dedication to improving pharmaceutical processes continues to benefit the industry and patients alike.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…